Chapter 5 – Lifestyle Factors and Sperm Quality
Abstract This chapter considers the effect of paternal age on semen analysis, sperm function and DNA damage, as well as age-related impact on male fertility, both natural conception (time to…
Chapter 4 – The Effect of Endocrine Disruptors and Environmental and Lifestyle Factors on the Sperm Epigenome
Abstract The sperm epigenome is unique and of profound clinical importance based on its role in influencing embryogenesis. Potentially, the sperm epigenome can also be of importance to the clinician…
Chapter 3 – Chromosome Abnormalities and the Infertile Male
Abstract Male infertility is a highly heterogeneous, multifactorial, complex pathology of the reproductive system, affecting approximately 7% of the general male population. Genetic factors are estimated to contribute to nearly…
Chapter 2 – New Horizons in Male Subfertility and Infertility
Abstract Male infertility is a common condition estimated to be a contributory factor in as many as 50% of couples experiencing problems with conception. It is also a key catalyst…
Chapter 1 – Sperm Selection for ART Success
Abstract This chapter describes techniques for the preparation of human spermatozoa for assisted conception. Traditional swim-up techniques depend on the intrinsic motility of human spermatozoa and have been used as…
Chapter 27 – Menopause in Primary Care
Abstract The other chapters of this book cover the diagnosis and management of menopause-related problems, the science behind them and the risks and benefits of the various interventions available. ‘Doing…
Chapter 25 – Non-hormonal Treatments for Menopausal Symptoms
Abstract There are a number of symptoms associated with perimenopause and decreasing estrogen levels, although some women will experience none of these. They include hot flashes and night sweats (vasomotor…
Chapter 26 – Alternative Therapies for the Management of Menopausal Symptoms
Abstract For the purpose of this chapter, we operationally define alternative therapies (ATs) as medical interventions which are not usually used in conventional medicine. Other terms frequently employed to describe…
Chapter 18 – The Use of Estrogens and Progestogens in Menopausal Hormone Therapy
Abstract In November 1929, clinicians first attempted to develop an ‘ovary stimulating hormone’ extracted from the human placenta for the treatment of symptoms resulting from the menopause. The team at…
Chapter 22 – Menopausal Hormone Therapy (MHT) and Venous Thrombosis
Abstract Venous thromboembolism (VTE) is a specific reproductive health risk for women. In pregnancy the relative risk of VTE is increased approximately 5-fold and in the puerperium it is increased…
